We’ve seen great strides in the development of MS treatments in recent years, from Gilenya in 2010 on through the advent of myelin peptides. Here’s a detailed look. ….
We’ve seen great strides in the development of MS treatments in recent years, from Gilenya in 2010 on through the advent of myelin peptides. Here’s a detailed look. ….
